Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genotype-Phenotype Correlations in Monogenic Parkinson Disease: A Review on Clinical and Molecular Findings
Daniele Guadagnolo, Maria Piane, Maria Rosaria Torrisi, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase
Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4176-4176
Open Access | Times Cited: 92
Mitochondrial Dysfunction and Parkinson’s Disease: Pathogenesis and Therapeutic Strategies
Sadegh Moradi Vastegani, Ava Nasrolahi, Shahab Ghaderi, et al.
Neurochemical Research (2023) Vol. 48, Iss. 8, pp. 2285-2308
Closed Access | Times Cited: 45
Genotype–phenotype correlation in PRKN-associated Parkinson’s disease
Poornima Jayadev Menon, Sara Sambin, Baptiste Criniere-Boizet, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 26
Sphingolipids in neurodegenerative diseases
Xueyang Pan, Debdeep Dutta, Shenzhao Lu, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 24
Towards a Global View of Parkinson's Disease Genetics
Marzieh Khani, Catalina Cerquera‐Cleves, Mariam Kekenadze, et al.
Annals of Neurology (2024) Vol. 95, Iss. 5, pp. 831-842
Open Access | Times Cited: 15
Genetic architecture of Parkinson’s disease subtypes – Review of the literature
Jarosław Dulski, Ryan J. Uitti, Owen A. Ross, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 34
Shaping the course of early-onset Parkinson’s disease: insights from a longitudinal cohort
Roberta Bovenzi, Matteo Conti, Giulia Rebecca Degoli, et al.
Neurological Sciences (2023) Vol. 44, Iss. 9, pp. 3151-3159
Open Access | Times Cited: 16
Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson’s disease
Henri Zenuni, Roberta Bovenzi, Jacopo Bissacco, et al.
Neurobiology of Aging (2023) Vol. 131, pp. 24-28
Open Access | Times Cited: 16
Extracellular Vesicles, Cell-Penetrating Peptides and miRNAs as Future Novel Therapeutic Interventions for Parkinson’s and Alzheimer’s Disease
Cameron Noah Keighron, Sahar Avazzadeh, Katarzyna Goljanek‐Whysall, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 728-728
Open Access | Times Cited: 14
X‐Linked Levodopa‐Responsive Parkinsonism‐Epilepsy Syndrome: A Novel PGK1 Mutation and Literature Review
Thiago Gonçalves Guimarães, Jacy Bezerra Parmera, Matheus Augusto Araújo Castro, et al.
Movement Disorders Clinical Practice (2024) Vol. 11, Iss. 5, pp. 556-566
Closed Access | Times Cited: 5
Unraveling Dysregulated Cell Signaling Pathways, Genetic and Epigenetic Mysteries of Parkinson’s Disease
Shayesteh Kokabi Hamidpour, Mobina Amiri, Arsh Haj Mohamad Ebrahim Ketabforoush, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 5
Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase
Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe, et al.
(2022)
Open Access | Times Cited: 20
The role of mitochondrial dynamics in disease
Yujuan Wang, Xinyan Dai, Hui Li, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 12
Clinical and genetic analysis of Vietnamese patients diagnosed with early‐onset Parkinson's disease
Duc M, Tai Ngoc Tran, Bac An Luong, et al.
Brain and Behavior (2023) Vol. 13, Iss. 4
Open Access | Times Cited: 11
Attention-deficit/hyperactivity disorder-related psychomotor activity and altered neuronal activity in the medial prefrontal cortex and striatum in the A53T mouse model of Parkinson's disease and other synucleinopathies: Findings from an “endophenotype” approach
Olga Dubljević, Željko Pavković, Maja Srbovan, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111273-111273
Closed Access
Next Generation Sequencing Analysis in Patients Affected by Parkinson’s Disease and Correlation Between Genotype and Phenotype in Selected Clinical Cases
Andrea Pilotto, Mattia Carini, Roberto Bresciani, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2397-2397
Open Access
Population-Specific Differences in Pathogenic Variants of Genes Associated with Monogenic Parkinson’s Disease
Victor Flores‐Ocampo, Wei Yin Lim, Natalia Ogonowski, et al.
Genes (2025) Vol. 16, Iss. 4, pp. 454-454
Open Access
The genetic landscape of sporadic adult-onset degenerative ataxia: a multi-modal genetic study of 377 consecutive patients from the longitudinal multi-centre SPORTAX cohort
Danique Beijer, David Mengel, Demet Önder, et al.
EBioMedicine (2025) Vol. 115, pp. 105715-105715
Closed Access
Recent Advances in the Treatment of Genetic Forms of Parkinson’s Disease: Hype or Hope?
Francesco Cavallieri, Rubens Gisbert Cury, Thiago Gonçalves Guimarães, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 764-764
Open Access | Times Cited: 10
Sortilin Expression Levels and Peripheral Immunity: A Potential Biomarker for Segregation between Parkinson’s Disease Patients and Healthy Controls
Maria Georgoula, Panagiotis Ntavaroukas, Anastasia Androutsopoulou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1791-1791
Open Access | Times Cited: 3
Genetic heterogeneity of early onset Parkinson disease: The dilemma of clinico-genetic correlation
Roopa Rajan, Vikram V. Holla, Nitish Kamble, et al.
Parkinsonism & Related Disorders (2024), pp. 107146-107146
Closed Access | Times Cited: 3
Psychosis in Parkinson’s Disease: A Lesson from Genetics
Efthalia Angelopoulou, Anastasia Bougea, Sokratis G. Papageorgiou, et al.
Genes (2022) Vol. 13, Iss. 6, pp. 1099-1099
Open Access | Times Cited: 15
The interplay of epilepsy with impaired mitophagy and autophagy linked dementia (MAD): A review of therapeutic approaches
Siva Prasad Panda, Yogita Dhurandhar, Mehak Agrawal
Mitochondrion (2022) Vol. 66, pp. 27-37
Closed Access | Times Cited: 10
Characterization of Lipopolysaccharide Effects on LRRK2 Signaling in RAW Macrophages
Asmaa Oun, Emmy Hoeksema, Ahmed Soliman, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1644-1644
Open Access | Times Cited: 5
Genetic Architecture of Parkinson’s Disease
М. И. Шадрина, P. A. Slominsky
Biochemistry (Moscow) (2023) Vol. 88, Iss. 3, pp. 417-433
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top